PPARγ1 attenuates cytosol to membrane translocation of PKCα to desensitize monocytes/macrophages
Open Access
- 26 February 2007
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 176 (5) , 681-694
- https://doi.org/10.1083/jcb.200605038
Abstract
Recently, we provided evidence that PKCalpha depletion in monocytes/macrophages contributes to cellular desensitization during sepsis. We demonstrate that peroxisome proliferator-activated receptor gamma (PPARgamma) agonists dose dependently block PKCalpha depletion in response to the diacylglycerol homologue PMA in RAW 264.7 and human monocyte-derived macrophages. In these cells, we observed PPARgamma-dependent inhibition of nuclear factor-kappaB (NF-kappaB) activation and TNF-alpha expression in response to PMA. Elucidating the underlying mechanism, we found PPARgamma1 expression not only in the nucleus but also in the cytoplasm. Activation of PPARgamma1 wild type, but not an agonist-binding mutant of PPARgamma1, attenuated PMA-mediated PKCalpha cytosol to membrane translocation. Coimmunoprecipitation assays pointed to a protein-protein interaction of PKCalpha and PPARgamma1, which was further substantiated using a mammalian two-hybrid system. Applying PPARgamma1 mutation and deletion constructs, we identified the hinge helix 1 domain of PPARgamma1 that is responsible for PKCalpha binding. Therefore, we conclude that PPARgamma1-dependent inhibition of PKCalpha translocation implies a new model of macrophage desensitization.Keywords
This publication has 50 references indexed in Scilit:
- Interaction with MEK Causes Nuclear Export and Downregulation of Peroxisome Proliferator-Activated Receptor γMolecular and Cellular Biology, 2007
- Significance of anti-inflammatory effects of PPAR agonists?Gut, 2005
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- Negative regulation of Toll-like receptor-mediated immune responsesNature Reviews Immunology, 2005
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-?? IS A NEW THERAPEUTIC TARGET IN SEPSIS AND INFLAMMATIONShock, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide productionAmerican Journal of Physiology-Cell Physiology, 2005
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Natural ligands of PPARγ:: Are prostaglandin J2 derivatives really playing the part?Cellular Signalling, 2002
- Nuclear Factor kB Is Activated by Arachidonic Acid but Not by Eicosapentaenoic AcidBiochemical and Biophysical Research Communications, 1996